Montelukast Tablets 5mg “CEO” (Montelukast Sodium) is manufactured by Ceolia Pharma, identified by YJ code 4490026F3063, with a standard of 5mg per tablet. This medication, a leukotriene receptor antagonist, is used for the prophylaxis and chronic treatment of asthma and to relieve symptoms of allergic rhinitis.
Montelukast Tablets 5mg “CEO”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
